Unknown

Dataset Information

0

Structural characterization of phosphoethanolamine-modified lipid A from probiotic Escherichia coli strain Nissle 1917.


ABSTRACT: Gut microbiota, a complex microbial community inhabiting human or animal intestines recently regarded as an endocrine organ, has a significant impact on human health. Probiotics can modulate gut microbiota and the gut environment by releasing a range of bioactive compounds. Escherichia coli (E. coli) strain Nissle 1917 (EcN), a Gram-negative bacterial strain, has been used to treat gastrointestinal (GI) disorders (i.e., inflammatory bowel disease, diarrhea, ulcerative colitis, and so on). However, endotoxicity of lipopolysaccharide (LPS), a major component of the cell wall of Gram-negative bacteria in the gut, is known to have a strong influence on gut inflammation and maintenance of gut homeostasis. Therefore, characterizing the chemical structure of lipid A which determines the toxicity of LPS is needed to understand nonpathogenic colonization and commensalism properties of EcN in the gut more precisely. In the present study, MALDI multiple-stage mass spectrometry analysis of lipid A extracted from EcN demonstrates that hexaacylated lipid A (m/z 1919.19) contains a glucosamine disaccharide backbone, a myristate, a laurate, four 3-hydroxylmyristates, two phosphates, and phosphoethanolamine (PEA). PEA modification of lipid A is known to contribute to cationic antimicrobial peptide (CAMP) resistance of Gram-negative bacteria. To confirm the role of PEA in CAMP resistance of EcN, minimum inhibitory concentrations (MICs) of polymyxin B and colistin were determined using a wild-type strain and a mutant strain with deletion of eptA gene encoding PEA transferase. Our results confirmed that MICs of polymyxin B and colistin for the wild-type were twice as high as those for the mutant. These results indicate that EcN can more efficiently colonize the intestine through PEA-mediated tolerance despite the presence of CAMPs in human gut such as human defensins. Thus, EcN can be used to help treat and prevent many GI disorders.

SUBMITTER: Jo SH 

PROVIDER: S-EPMC9065436 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural characterization of phosphoethanolamine-modified lipid A from probiotic <i>Escherichia coli</i> strain Nissle 1917.

Jo Sung-Hyun SH   Park Han-Gyu HG   Song Won-Suk WS   Kim Seong-Min SM   Kim Eun-Jung EJ   Yang Yung-Hun YH   Kim Jae-Seok JS   Kim Byung-Gee BG   Kim Yun-Gon YG  

RSC advances 20190625 34


Gut microbiota, a complex microbial community inhabiting human or animal intestines recently regarded as an endocrine organ, has a significant impact on human health. Probiotics can modulate gut microbiota and the gut environment by releasing a range of bioactive compounds. <i>Escherichia coli</i> (<i>E. coli</i>) strain Nissle 1917 (EcN), a Gram-negative bacterial strain, has been used to treat gastrointestinal (GI) disorders (<i>i.e.</i>, inflammatory bowel disease, diarrhea, ulcerative coliti  ...[more]

Similar Datasets

| S-EPMC7215827 | biostudies-literature
| S-EPMC5987069 | biostudies-literature
| S-EPMC490877 | biostudies-literature
| S-EPMC3495787 | biostudies-literature
| S-EPMC5670229 | biostudies-literature
| S-EPMC1802727 | biostudies-literature
| S-EPMC8386472 | biostudies-literature
2018-06-14 | GSE109932 | GEO
| S-EPMC9468890 | biostudies-literature
2013-12-19 | PXD000367 | Pride